Precigen, Inc. (PGEN) Provides Six-month Follow-up Data from Phase I Study of INXN-4001

Go back to Precigen, Inc. (PGEN) Provides Six-month Follow-up Data from Phase I Study of INXN-4001
(NASDAQ: PGEN) Delayed: 7.78 --0 (-0%)
Previous Close $7.78    52 Week High
Open $7.78    52 Week Low
Day High $7.78    P/E N/A 
Day Low $7.78    EPS
Volume 88,920